An improved protocol for generation and characterization of human-induced pluripotent stem cell-derived retinal pigment epithelium cells-Reference-Cited by-同舟云学术

An improved protocol for generation and characterization of human-induced pluripotent stem cell-derived retinal pigment epithelium cells

Published:2022-12 Issue:4 Volume:3 Page:101803
ISSN:2666-1667
Container-title:STAR Protocols
language:en
Short-container-title:STAR Protocols

Author:

Surendran Harshini,Soundararajan Lalitha,Reddy K Vijay Bhaskar,Subramani Janavi,Stoddard Jonathan,Reynaga Rene,Tschetter Wayne,Ryals Renee C.,Pal Rajarshi

Publisher

Elsevier BV

Subject

General Immunology and Microbiology,General Biochemistry, Genetics and Molecular Biology,General Neuroscience

Reference5 articles.

1. cGMP-manufactured human induced pluripotent stem cells are available for pre-clinical and clinical applications;Baghbaderani;Stem Cell Rep.,2015

2. Derivation of three induced pluripotent stem cell lines under feeder-free culture conditions from peripheral blood mononuclear cells (PBMC) of Indian patients suffering from inherited retinal diseases carrying different mutations;Konala;Stem Cell Res.,2020

3. Transplantation of retinal pigment epithelium and photoreceptors generated concomitantly via small molecule-mediated differentiation rescues visual function in rodent models of retinal degeneration;Surendran;Stem Cell Res. Ther.,2021

4. Generation of transplantable retinal pigmented epithelial (RPE) cells for treatment of age-related macular degeneration (AMD);Surendran;Methods Mol. Biol.,2019

5. Subretinal cell-based therapy: an analysis of surgical variables to increase cell survival;Wilson;Retina,2017

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimizing cryopreservation strategies for scalable cell therapies: A comprehensive review with insights from iPSC‐derived therapies;Biotechnology Progress;2024-09-13

2. Generation and characterization of retinal pigment epithelium from patient iPSC line to model oculocutaneous albinism (OCA)1A disease;Journal of Biosciences;2024-01-20